Tocilizumab for COVID-19: a real 'miracle drug'?
Saved in:
| Title: | Tocilizumab for COVID-19: a real 'miracle drug'? |
|---|---|
| Authors: | Nasim S; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Hashmi SH; NYU Grossman School of Medicine, New York City, NY, USA., Azim D; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Kumar S; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan., Nasim J; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan. |
| Source: | Infectious diseases (London, England) [Infect Dis (Lond)] 2020 Sep; Vol. 52 (9), pp. 681-682. Date of Electronic Publication: 2020 Jun 17. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Informa Healthcare Country of Publication: England NLM ID: 101650235 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2374-4243 (Electronic) Linking ISSN: 23744243 NLM ISO Abbreviation: Infect Dis (Lond) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32644027 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tocilizumab for COVID-19: a real 'miracle drug'? – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nasim+S%22">Nasim S</searchLink>; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Hashmi+SH%22">Hashmi SH</searchLink>; NYU Grossman School of Medicine, New York City, NY, USA.<br /><searchLink fieldCode="AU" term="%22Azim+D%22">Azim D</searchLink>; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Kumar+S%22">Kumar S</searchLink>; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Nasim+J%22">Nasim J</searchLink>; Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101650235%22">Infectious diseases (London, England)</searchLink> [Infect Dis (Lond)] 2020 Sep; Vol. 52 (9), pp. 681-682. <i>Date of Electronic Publication: </i>2020 Jun 17. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Informa+Healthcare%22">Informa Healthcare </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101650235 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2374-4243 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744243%22">23744243 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis (Lond) <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32644027 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/23744235.2020.1780307 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 681 Titles: – TitleFull: Tocilizumab for COVID-19: a real 'miracle drug'? Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nasim S – PersonEntity: Name: NameFull: Hashmi SH – PersonEntity: Name: NameFull: Azim D – PersonEntity: Name: NameFull: Kumar S – PersonEntity: Name: NameFull: Nasim J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2020 Sep Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 2374-4243 Numbering: – Type: volume Value: 52 – Type: issue Value: 9 Titles: – TitleFull: Infectious diseases (London, England) Type: main |
| ResultId | 1 |
